Edith Nalbandian is an experienced scientist in product development with technical expertise in cell-based assay design for cell and gene therapies as well as biotherapeutics. In her current role, she leads the Potency Team at Tune Therapeutics. Prior to joining Tune, she worked at Juno/Celgene/BMS where she led the development of both Drug Product as well as Vector Potency release methods. She started her industry career at Amgen where she supported early and late-stage potency release method design and execution.